Electra Therapeutics(ETRA.US)递交美股IPO申请，借生物科技上市热潮推进免疫疾病与癌症新药研发

智通财经08-29 11:05

【Electra Therapeutics(ETRA.US)递交美股IPO申请，借生物科技上市热潮推进免疫疾病与癌症新药研发】智通财经APP获悉，生物科技公司Electra Therapeutics Inc.(ETRA.US)已正式递交首次公开募股(IPO)申请，欲借今年生物科技板块IPO强劲表现的东风，为其处于临床阶段的免疫介导疾病和癌症药物管线筹集资金。

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohunote.com/m/news/2663011439?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-08-29 11:05","share_image_url":"https://static.laohu8.com/6ca2dcdccfa2217fb20a0351f4efe814","id":"2663011439","market":"us","top_or_hot":-1,"title":"Electra Therapeutics(ETRA.US)递交美股IPO申请，借生物科技上市热潮推进免疫疾病与癌症新药研发","media":"智通财经","content":"<html><body><div>\n<div>\n<b>【Electra Therapeutics(ETRA.US)递交美股IPO申请，借生物科技上市热潮推进免疫疾病与癌症新药研发】</b>智通财经APP获悉，生物科技公司Electra Therapeutics \n\nInc.(ETRA.US)已正式递交首次公开募股(IPO)申请，欲借今年生物科技板块IPO强劲表现的东风，为其处于临床阶段的免疫介导疾病和癌症药物管线筹集资金。                </div>\n</div></body></html>","source":"live_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Electra Therapeutics(ETRA.US)递交美股IPO申请，借生物科技上市热潮推进免疫疾病与癌症新药研发</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nElectra Therapeutics(ETRA.US)递交美股IPO申请，借生物科技上市热潮推进免疫疾病与癌症新药研发\n</h2>\n\n<h4 class=\"meta\">\n\n</h4>\n\n</header>\n<article>\n<html><body><div>\n<div>\n<b>【Electra Therapeutics(ETRA.US)递交美股IPO申请，借生物科技上市热潮推进免疫疾病与癌症新药研发】</b>智通财经APP获悉，生物科技公司Electra Therapeutics \n\nInc.(ETRA.US)已正式递交首次公开募股(IPO)申请，欲借今年生物科技板块IPO强劲表现的东风，为其处于临床阶段的免疫介导疾病和癌症药物管线筹集资金。                </div>\n</div></body></html>\n\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.zhitongcaijing.com/immediately.html?type=usstock\">智通财经</a> </p>\n\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n</div>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"FRHC","symbol_name":"Euronext CAC Health Care","start_time":0,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","article_id":"2663011439","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2663011439","pubTimestamp":1787972713,"columns":[],"sourceInfo":{"source_id":"live_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"【Electra Therapeutics(ETRA.US)递交美股IPO申请，借生物科技上市热潮推进免疫疾病与癌症新药研发】智通财经APP获悉，生物科技公司Electra Therapeutics ","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"FRHC":"Euronext CAC Health Care","IPOS":"Renaissance International IPO ETF","REDS":"RPM Republican Senate ETF","LNGR":"Global X Longevity Thematic ETF","BK4539":"次新股","KCE":"SPDR KBW Capital Markets ETF","BK4581":"高盛持仓","AGNG":"Global X Aging Population ETF","XBI":"SPDR S&P Biotech ETF","MEDX":"HORIZON KINETICS MEDICAL ETF","BK4585":"ETF&股票定投概念","LENZ":"Therapeutics","BK4127":"投资银行业与经纪业","BK4139":"生物科技","SYNB":"PUTNAM BIOREVOLUTION ETF","IBBJ":"Defiance Nasdaq Junior Biotechnology ETF","IEIH":"iShares Evolved U.S. Innovative Healthcare ETF","GDOC":"Goldman Sachs Future Health Care Equity ETF","BK4007":"制药","BK4588":"碎股"},"translate_title":"Electra Therapeutics (ETRA.US) has filed for an IPO on the US stock market, taking advantage of the boom in biotechnology listings to advance the development of new drugs for immune diseases and cancer.","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IBBJ":1.5,"IPOS":1.5,"GDOC":1.5,"SYNB":1.5,"KCE":1.5,"LNGR":1.5,"IEIH":1.5,"LENZ":1.5,"FRHC":1.5,"MEDX":1.5,"AGNG":1.5,"XBI":1.5,"REDS":1.5},"content_text":"【Electra Therapeutics(ETRA.US)递交美股IPO申请，借生物科技上市热潮推进免疫疾病与癌症新药研发】智通财经APP获悉，生物科技公司Electra Therapeutics \n\nInc.(ETRA.US)已正式递交首次公开募股(IPO)申请，欲借今年生物科技板块IPO强劲表现的东风，为其处于临床阶段的免疫介导疾病和癌症药物管线筹集资金。","kind":"live","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":true,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2663011439","isCrawlerRequest":true}